Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8651789 | The American Journal of the Medical Sciences | 2018 | 22 Pages |
Abstract
Monitoring CRC patients' molecular changes in response to treatment via CTCs and ctDNA can provide real-time information to disease changes. The study demonstrated that the emergence of secondary mutations were strongly associated to poorer survival after treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Qiushi MEng, MD, Yuan MMed, MD, Bo MMed, MD, Yingying MMed, MD,